Vermehren, J.
548  Ergebnisse:
Personensuche X
?
2

High efficacy of sofosbuvir/velpatasvir and impact of basel..:

von Felden, J. ; Vermehren, J. ; Ingiliz, P....
Alimentary Pharmacology & Therapeutics.  47 (2018)  9 - p. 1288-1295 , 2018
 
?
3

Impact of HBV genotype and mutations on HBV DNA and qHBsAg ..:

Kuhnhenn, L. ; Jiang, B. ; Kubesch, A....
Alimentary Pharmacology & Therapeutics.  47 (2018)  11 - p. 1523-1535 , 2018
 
?
4

Editorial: genotype 3 HCV—who still needs ribavirin in a pa..:

von Felden, J. ; Vermehren, J. ; Schulze zur Wiesch, J...
Alimentary Pharmacology & Therapeutics.  47 (2018)  11 - p. 1550-1551 , 2018
 
?
 
?
7

A175 CAN HCV CORE ANTIGEN REPLACE HCV RNA TESTING IN THE ER..:

Almarzooqi, S ; van Tilborg, M ; Maan, R...
Journal of the Canadian Association of Gastroenterology.  1 (2018)  suppl_1 - p. 305-306 , 2018
 
?
8

Letter: adoption of uniform nomenclature is crucial for est..:

Mücke, M. M. ; Mücke, V. T. ; Vermehren, J.
Alimentary Pharmacology & Therapeutics.  47 (2018)  11 - p. 1573-1574 , 2018
 
?
 
?
 
?
13

No evidence of hepatitis B virus reactivation in patients w..:

Mücke, V. T. ; Mücke, M. M. ; Peiffer, K.‐H....
Alimentary Pharmacology & Therapeutics.  46 (2017)  4 - p. 432-439 , 2017
 
1-15